KRSA Korsana Biosciences, Inc.: institutional ownership and insider trading
21 funds reported holding $11.2M of Korsana Biosciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $10.6M, with 9 new positions and 5 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
KRSA revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$1.76M, EPS -0.41
- Quarter ended Mar 31, 2026: revenue $0, net income −$3.18M, EPS -0.76
- Quarter ended Dec 31, 2025: revenue $1.03M, net income −$799K, EPS -0.14
- Quarter ended Sep 30, 2025: revenue $875K, net income −$976K, EPS -0.30
Famous investors holding KRSA
- Ken Griffin (Citadel Advisors): $203K, 0.0% of the portfolio
Largest institutional holders of KRSA
- Kalehua Capital Management LLC — $5.60M
- FMR LLC — $2.20M
- BALYASNY ASSET MANAGEMENT L.P. — $1.08M
- ADAR1 Capital Management, LLC — $1.01M
- BRAIDWELL LP — $532K
- CITADEL ADVISORS LLC — $203K
- GEODE CAPITAL MANAGEMENT, LLC — $155K
- VANGUARD CAPITAL MANAGEMENT LLC — $105K
- Rangeley Capital, LLC — $82.4K
- HRT FINANCIAL LP — $74.0K
Recent KRSA insider trades
- Nov 21, 2024: Slate Path Capital LP sold 357,880 shares ($555K)
5%+ owners
- Peter M. Hecht: 19.4% (Schedule 13D/A, filed Jul 20, 2026)
- FMR LLC: 15.0% (Schedule 13G, filed May 7, 2026)
- BALYASNY ASSET MANAGEMENT L.P.: 7.3% (Schedule 13G, filed Aug 14, 2026)
- ADAR1 Capital Management, LLC: 7.0% (Schedule 13G, filed Aug 14, 2026)
Who owns the most KRSA stock?
The largest institutional holders of Korsana Biosciences, Inc. in the latest 13F filings are Kalehua Capital Management LLC ($5.60M), FMR LLC ($2.20M), BALYASNY ASSET MANAGEMENT L.P. ($1.08M).
Are insiders buying or selling KRSA?
No open-market insider buys or sells of Korsana Biosciences, Inc. were reported in the last 12 months.
Which famous investors own KRSA?
Ken Griffin.